Professional | Anxiety and Depression Association of America, ADAA

November 21, 2023

Social Connection and Support as Targets for Youth Suicide Prevention

Cheryl King, PhD and

This presentation (sponsored by ADAA's Suicide and Self-Injury Special Interest Group) reviews converging empirical evidence arguing for the importance of belongingness and connectedness to youth suicide risk and prevention.

More Info

Diversity, Equity, and Inclusion Resources - Professionals

A Values-Based Approach to a New Year and a New You: Embracing the Process

Thursday, December 21, 2023 - 18:43

As the New Year approaches, many of us are drawn to the idea of starting fresh and making resolutions for positive change. However, traditional New Year's resolutions often focus on specific outcomes, setting us up for potential disappointment and loss of momentum.

Become a Member / Categories & Fees

ADAA is the only multidisciplinary professional organization engaging the world’s leading experts focused on anxiety and depressive disorders in children and adults. Discover member rates and join today. Questions? Email [email protected].

ADAA Professional Membership Benefits

ADAA membership offers an extensive list of learning, networking and publication benefits available to you through your ADAA membership.

Michelle Patriquin, PhD, ABPP - ADAA Board Member

Michelle Patriquin, PhD, ABPP
Co-Director of Research, John S. Dunn Center Behavioral Sciences Center
Assistant Dean, Digital Health & Innovation, School of Behavioral Health Sciences
Associate Professor, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School

Diego Pizzagalli, PhD - ADAA Board Member

Diego Pizzagalli, PhD
McLean Hospital

Allison LoPilato, PhD, LCSW, ABPP -ADAA Board

Allison LoPilato, PhD, LCSW, ABPP
Emory University

The Role of Antipsychotics in OCD

Wednesday, December 13, 2023 - 06:24

Successfully treating obsessive-compulsive disorder (OCD) often requires primary psychotherapeutic treatment with exposure and response prevention (ERP) and pharmacological treatment with serotonergic agents, typically beginning with SSRIs; however, for a subset of patients with OCD, SSRIs alone do not effectively manage symptoms.

The Interplay Between PTSD and OCD: Treatment Considerations and Tactics